Literature DB >> 7534922

Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.

B F Crandall1, P Kulch, K Tabsh.   

Abstract

We studied 693 consecutive early amniocenteses (prior to 15 weeks) and found a spontaneous abortion rate to 28 weeks' gestation of 1.5 per cent. A control group of women having standard amniocentesis (15-20 weeks) experienced a 0.6 per cent fetal loss in the same period. There were no other apparent differences between the two groups. Early amniocentesis results are generally available 4-6 weeks before standard amniocentesis and 1-3 weeks after chorionic villus sampling (CVS). Alpha-fetoprotein (AFP) can be accurately assayed in 11- to 15-week amniotic fluid samples but additional studies are necessary to determine the accuracy of neural tube defect (NTD) detection. Including the present study, over 5800 early amniocenteses have been reported and the results suggest that this is a relatively safe prenatal diagnostic test and an alternative to CVS and later amniocentesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534922     DOI: 10.1002/pd.1970141004

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

1.  Club foot, an adverse outcome of early amniocentesis: disruption or deformation? CEMAT. Canadian Early and Mid-Trimester Amniocentesis Trial.

Authors:  S A Farrell; A M Summers; L Dallaire; J Singer; J A Johnson; R D Wilson
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

2.  The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform.

Authors:  Young Joo Jeon; Yulin Zhou; Yihan Li; Qiwei Guo; Jinchun Chen; Shengmao Quan; Ahong Zhang; Hailing Zheng; Xingqiang Zhu; Jin Lin; Huan Xu; Ayang Wu; Sin-Gi Park; Byung Chul Kim; Hee Jae Joo; Hongliang Chen; Jong Bhak
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

3.  An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.

Authors:  Sunshin Kim; HeeJung Jung; Sung Hee Han; SeungJae Lee; JeongSub Kwon; Min Gyun Kim; Hyungsik Chu; Kyudong Han; Hwanjong Kwak; Sunghoon Park; Hee Jae Joo; Minae An; Jungsu Ha; Kyusang Lee; Byung Chul Kim; Hailing Zheng; Xinqiang Zhu; Hongliang Chen; Jong Bhak
Journal:  BMC Med Genomics       Date:  2016-10-03       Impact factor: 3.063

4.  Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy.

Authors:  Sunshin Kim; HeeJung Jung; Sung Hee Han; SeungJae Lee; JeongSub Kwon; Min Gyun Kim; Hyungsik Chu; Hongliang Chen; Kyudong Han; Hwanjong Kwak; Sunghoon Park; Hee Jae Joo; Byung Chul Kim; Jong Bhak
Journal:  BMC Med Genomics       Date:  2016-04-30       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.